Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions

A modified comparative genomic hybridization (mCGH) technique was used to identify and map amplified DNA sequences in six homogeneously staining regions (hsr) from three primary breast carcinomas. Five different chromosomal regions and bands were identified as sites of amplification: 8p1, 17q21.1, 17q23 (two cases), 19q13.3, and 20q13.3. The mCGH site located on 17q21.1 was demonstrated to correspond to a 50–100‐fold amplification of ERBB2. Further in situ hybridization experiments were used to confirm the mCGH results and to characterize the organization of the amplified sequences within the hsr. In five of six instances, two or more chromosomal regions were found amplified in the same hsr. In the tumor with the less modified karyotype, the two hsr comprised DNA sequences from three different chromosomes and showed different patterns of amplification. In the tumor with the most rearranged karyotype, the hsr‐carrying chromosomes were formed by the translocation and amplification of sequences from three or four different chromosomal sites. This illustrates the complexity of the amplification process in breast cancers.

[1]  K. B. Petersen,et al.  Application of fluorescence in situ hybridization techniques in clinical genetics: use of two alphoid repeat probes detecting the centromeres of chromosomes 13 and 21 or chromosomes 14 and 22, respectively , 1991, Clinical genetics.

[2]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Meltzer,et al.  Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.

[4]  J. Erickson,et al.  Variation among human 28S ribosomal RNA genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Dutrillaux,et al.  Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique , 1994, Genes, chromosomes & cancer.

[6]  B. Dutrillaux,et al.  The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer , 1994, Genes, chromosomes & cancer.

[7]  B. Dutrillaux,et al.  Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes. , 1991, Cancer genetics and cytogenetics.

[8]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[9]  J. Delattre,et al.  Oncogene amplification in human gliomas: a molecular cytogenetic analysis. , 1994, Oncogene.

[10]  B. Roe,et al.  Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells , 1984, Nature.

[11]  N. Nomura,et al.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.

[12]  B. Dutrillaux,et al.  Proto‐oncogene amplification and homogeneously staining regions in human breast carcinomas , 1990, Genes, chromosomes & cancer.

[13]  Y. Nakamura,et al.  Isolation and mapping of 88 new RFLP markers on human chromosome 8. , 1992, Genomics.

[14]  G. Thomas,et al.  Mapping of 18 probes on human chromosome 18 using single- and double-color FISH. , 1994, Cytogenetics and cell genetics.

[15]  H. Willard,et al.  Structure, organization, and sequence of alpha satellite DNA from human chromosome 17: evidence for evolution by unequal crossing-over and an ancestral pentamer repeat shared with the human X chromosome , 1986, Molecular and cellular biology.

[16]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.